Description
Why It’s Done:
The test is used to:
• Confirm diagnosis of Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
• Detect the Philadelphia chromosome when conventional cytogenetics is inconclusive or unavailable
• Monitor residual disease and response to therapy in patients under treatment
• Guide treatment decisions, especially regarding targeted therapies like tyrosine kinase inhibitors
Preparation:
• No special preparation is required.
• A blood sample or bone marrow aspirate will be collected.
• Inform your healthcare provider of any recent treatments or medications.
• No fasting or dietary restrictions are necessary before the test.
